Related Experiment Video

Updated: May 3, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

17.1K

Post-exposure tuberculosis in children under 5 years old

    Prescrire International
    |February 12, 2014
    PubMed

    Insights

    Young children under five face a high risk of tuberculosis (TB) infection after exposure to an infectious individual. This retrospective US study highlights critical pediatric TB risks.

    Area of Science:

    • Public Health
    • Infectious Diseases
    • Pediatrics

    Background:

    • Tuberculosis (TB) remains a significant global health concern.
    • Understanding transmission dynamics in vulnerable populations is crucial for effective control strategies.

    Purpose of the Study:

    • To assess the risk of tuberculosis infection in children under five years old following exposure to infectious TB patients.
    • To identify high-risk groups within the pediatric population for targeted interventions.

    Main Methods:

    • Retrospective study design utilizing data from a large cohort in the United States.
    • Analysis of exposure events between infectious tuberculosis patients and children under five.
    • Evaluation of infection rates and risk factors.

    Main Results:

    • Children under the age of five demonstrated a significantly elevated risk of contracting tuberculosis post-exposure.
    • The study confirms a high susceptibility in this young age group to TB transmission.

    Conclusions:

    • Urgent public health measures are needed to protect young children from tuberculosis.
    • Enhanced preventive strategies and early detection are vital for pediatric TB control.

    More Related Videos

    Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice06:32

    Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

    Published on: September 19, 2016

    9.8K
    Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis06:26

    Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

    Published on: July 28, 2023

    3.0K

    Related Concept Videos

    Pulmonary Tuberculosis IV01:26

    Pulmonary Tuberculosis IV

    Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
    Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
    828
    Pulmonary Tuberculosis I01:29

    Pulmonary Tuberculosis I

    Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
    Causative Organism
    The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
    Mode of...
    1.7K
    Pulmonary Tuberculosis III01:31

    Pulmonary Tuberculosis III

    Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
    The first classification is based on the development of the disease, and it includes the following categories:
    1.8K
    Pulmonary Tuberculosis V01:28

    Pulmonary Tuberculosis V

    Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
    Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
    1.0K
    Pulmonary Tuberculosis II01:28

    Pulmonary Tuberculosis II

    Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
    Here is a detailed explanation of its pathophysiology:
    Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
    2.5K
    Transmission-based Precautions II: Airborne and Protective Environment01:25

    Transmission-based Precautions II: Airborne and Protective Environment

    Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
    Airborne precautions:
    Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
    2.0K